nonprofit organization
Mental Health Foundation
GB
People
Connected researchers
Alison R YungORCID 0000-0002-0401-9791Diego QuattroneORCID 0000-0002-6051-8309Edoardo SpinazzolaORCID 0000-0002-8070-0618Edward ChesneyORCID 0000-0003-2851-5252Evangelos VassosORCID 0000-0001-6363-0438Giulia TrottaORCID 0000-0003-2801-9718Marta Di FortiORCID 0000-0002-3218-6925Musa SamiORCID 0000-0002-4420-8618Pak C. ShamORCID 0000-0002-2533-7270Robin M. MurrayORCID 0000-0003-0829-0519
Public evidence
9 connected articles
Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.2026 · Europe PMCThe impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCAssociations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users2023 · PubMed Central Open AccessThe association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMCCannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank.2021 · PubMed Central Open AccessDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open AccessAdverse effects of heavy cannabis use: even plants can harm the brain.2021 · PubMed Central Open AccessDo AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?2020 · PubMed Central Open AccessThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: OpenAlex.